Cargando…

MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer

BACKGROUND: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. MicroRNAs (miRNAs) are involved in essential biological activities, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lin, Zhang, Yuqin, Liu, Yan, Zhou, Min, Lu, Yanxia, Yuan, Li, Zhang, Chao, Hong, Min, Wang, Shuang, Li, Xuenong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522974/
https://www.ncbi.nlm.nih.gov/pubmed/26238857
http://dx.doi.org/10.1186/s12967-015-0592-z
_version_ 1782384019524026368
author Zheng, Lin
Zhang, Yuqin
Liu, Yan
Zhou, Min
Lu, Yanxia
Yuan, Li
Zhang, Chao
Hong, Min
Wang, Shuang
Li, Xuenong
author_facet Zheng, Lin
Zhang, Yuqin
Liu, Yan
Zhou, Min
Lu, Yanxia
Yuan, Li
Zhang, Chao
Hong, Min
Wang, Shuang
Li, Xuenong
author_sort Zheng, Lin
collection PubMed
description BACKGROUND: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. MicroRNAs (miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. Several research studies have indicated that miRNA played an important role in sensitizing cells to ionizing radiation (IR). MiR-106b, a member of the miR-106b-25 cluster, is frequently dysregulated in many human cancers, including CRC. However, the function of miR-106b in radioresistance is currently poorly understood. METHODS: A series of in vitro and in vivo studies were performed to investigate the roles of miR-106b on cell radioresistance in CRC. RESULTS: We found overexpression of miR-106b could induce resistance to IR in vitro and in vivo in SW620 cells. Correspondingly, knocking down miR-106b in SW480 yielded the opposite effect. In addition, overexpression of miR-106b could enhance the tumour-initiating cell capacity without or with IR condition, such as the colony sphere formation capacity and the upregulation of stemness-related genes (CD133, Sox2). We further identified PTEN and p21 as novel direct targets of miR-106b by using target prediction algorithms and a luciferase assay. Overexpression of miR-106b reduced the expression of PTEN and p21 and increased the expression of p-AKT, which is a downstream of PTEN. Restoring the expression of PTEN or p21 in stably miR-106b-overexpressed cells could rescue the effect of miR-106b on cell radioresistance. Together, the acquisition of tumour-initiating cell capacity endowed CRC cells with the potential of resistance to irradiation. CONCLUSIONS: These observations illustrated that miR-106b could induce cell radioresistance by directly targeting PTEN and p21, this process was accompanied by tumour-initiating cell capacity enhancement, which is universally confirmed to be associated with radioresistance. Our data suggested that miR-106b at least partly induces cell radioresistance in CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0592-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4522974
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45229742015-08-04 MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer Zheng, Lin Zhang, Yuqin Liu, Yan Zhou, Min Lu, Yanxia Yuan, Li Zhang, Chao Hong, Min Wang, Shuang Li, Xuenong J Transl Med Research BACKGROUND: Radioresistance is a challenge in the treatment of patients with colorectal cancer (CRC). Individuals display different therapeutic responses to preoperative radiotherapy, and the need of targeted therapies is urgent. MicroRNAs (miRNAs) are involved in essential biological activities, including chemoresistance and radioresistance. Several research studies have indicated that miRNA played an important role in sensitizing cells to ionizing radiation (IR). MiR-106b, a member of the miR-106b-25 cluster, is frequently dysregulated in many human cancers, including CRC. However, the function of miR-106b in radioresistance is currently poorly understood. METHODS: A series of in vitro and in vivo studies were performed to investigate the roles of miR-106b on cell radioresistance in CRC. RESULTS: We found overexpression of miR-106b could induce resistance to IR in vitro and in vivo in SW620 cells. Correspondingly, knocking down miR-106b in SW480 yielded the opposite effect. In addition, overexpression of miR-106b could enhance the tumour-initiating cell capacity without or with IR condition, such as the colony sphere formation capacity and the upregulation of stemness-related genes (CD133, Sox2). We further identified PTEN and p21 as novel direct targets of miR-106b by using target prediction algorithms and a luciferase assay. Overexpression of miR-106b reduced the expression of PTEN and p21 and increased the expression of p-AKT, which is a downstream of PTEN. Restoring the expression of PTEN or p21 in stably miR-106b-overexpressed cells could rescue the effect of miR-106b on cell radioresistance. Together, the acquisition of tumour-initiating cell capacity endowed CRC cells with the potential of resistance to irradiation. CONCLUSIONS: These observations illustrated that miR-106b could induce cell radioresistance by directly targeting PTEN and p21, this process was accompanied by tumour-initiating cell capacity enhancement, which is universally confirmed to be associated with radioresistance. Our data suggested that miR-106b at least partly induces cell radioresistance in CRC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12967-015-0592-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-04 /pmc/articles/PMC4522974/ /pubmed/26238857 http://dx.doi.org/10.1186/s12967-015-0592-z Text en © Zheng et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zheng, Lin
Zhang, Yuqin
Liu, Yan
Zhou, Min
Lu, Yanxia
Yuan, Li
Zhang, Chao
Hong, Min
Wang, Shuang
Li, Xuenong
MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
title MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
title_full MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
title_fullStr MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
title_full_unstemmed MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
title_short MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
title_sort mir-106b induces cell radioresistance via the pten/pi3k/akt pathways and p21 in colorectal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522974/
https://www.ncbi.nlm.nih.gov/pubmed/26238857
http://dx.doi.org/10.1186/s12967-015-0592-z
work_keys_str_mv AT zhenglin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT zhangyuqin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT liuyan mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT zhoumin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT luyanxia mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT yuanli mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT zhangchao mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT hongmin mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT wangshuang mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer
AT lixuenong mir106binducescellradioresistanceviatheptenpi3kaktpathwaysandp21incolorectalcancer